Ipca Laboratories Ltd.

BSE : 124494 NSE : IPCALAB ISIN : INE571A01038 Industry : Pharmaceuticals & Drugs
1,149.70
Change: 16.75 (1.48 %)
As on 01-Dec-2023 12:00 AM
Prev.Close 1,132.95
Open 1,133.00
Day's High 1,153.00
Day's Low 1,123.95
Mkt.Cap ( Cr.) 29,168.35
Face Value 1.00
PE Ratio 58.38
PB Ratio 3.50

52 Week High Low

Low: 669.80
High: 1,153.00
LTP:1,149.70

Lifetime High Low

Low: 2.75
High: 1,383.10
LTP:1,149.70

Ipca Laboratories Ltd.

BSE : 124494 NSE : IPCALAB ISIN : INE571A01038 Industry : Pharmaceuticals & Drugs
1,148.50
B S Sip
Change: 15.75 (1.39 %)
As on 01-Dec-2023 12:00 AM
Prev.Close 1,132.75
Open 1,132.75
Day High 1,152.55
Day Low 1,125.00
Mkt.Cap ( Cr. ) 29,137.90
Face Value 1.00
P/E Ratio 58.38
PB Ratio 3.50

52 Week High Low

Low:670.00
High:1,152.55
LTP:1,148.50

Lifetime High Low

Low:2.83
High:1,383.55
LTP:1,148.50

P/E Ratio

52 W L(14.96)
52 W H(40.26)

P/E Ratio

52 W L(14.96)
52 W H(40.26)
Had I Invested a sum of 1,00,000 on the same day 5 years ago,the money would have become 285817.28 ( a of 23.37 p.a.)

Key Levels

Support Level 1 1,120.17
Support Level 2 1,107.38
Resistance Level 1 1,141.87
Resistance Level 2 1,150.78

Moving Average

20 Days 1,056.02
50 Days 989.37
100 Days 924.64
200 Days 846.62
Jubilant Pharmova Ltd. 453.05 Change: 23.60 (5.50%)
PE : 0.00
1Y Return: 15.71%

B S
Vineet Laboratories Ltd. 70.60 Change: 2.75 (4.05%)
PE : 10.18
1Y Return: 23.75%

B S
Orchid Pharma Ltd. 589.50 Change: 20.85 (3.67%)
PE : 30.08
1Y Return: 48.36%

B S
Aarti Pharmalabs Ltd. 425.50 Change: 13.85 (3.36%)
PE : 19.28
1Y Return: 0.00%

B S
FY 2023FY 2022FY 2021FY 2020FY 2019
EBDITA Margin (%)17.6423.8030.7222.5020.65
PBT Margin (%)12.9119.7526.8517.9715.34
PAT Margin (%)8.7015.8222.2014.9412.52
ROCE (%)11.7719.3430.5420.8416.76
ROE (%)8.9116.8227.1019.1815.60
FY 2023FY 2022FY 2021FY 2020FY 2019
Total Income ( Cr.)5,912.065,514.185,242.714,421.983,677.23
Gross Profit ( Cr.)979.121,283.761,567.68963.66729.27
Profit Before Tax ( Cr.)750.491,074.111,379.96784.97557.39
Tax ( Cr.)244.79213.74239.19132.51102.48
Profit After Tax ( Cr.)505.70860.371,140.77652.46454.91
NAME DESIGNATION
Harish P Kamath Corporate Counsel & Company Secretary
Premchand Godha Chairman
Ajit Kumar Jain Managing Director
Pranay Godha Managing Director
Prashant Godha Executive Director
Anand T Kusre Non Executive Independent Director
Manisha Premnath Non Executive Independent Director
Kamal Kishore Seth Non Executive Independent Director
Narendra Mairpady Non Executive Independent Director
Scheme Name AUM% Value(Rs. Cr.) Holding Date
HDFC Mid-Cap Opportunities Fund - Growth Know More 2.77 1,326.74 31-Oct-2023
Kotak Emerging Equity Fund - Growth Know More 2.05 689.91 31-Oct-2023
DSP Midcap Fund - Regular Plan - Growth Know More 3.88 561.21 31-Oct-2023
Parag Parikh Flexi Cap Fund - Regular Plan - Growth Know More 0.79 348.43 31-Oct-2023
DSP Small Cap Fund - Regular Plan - Growth Know More 2.68 317.71 31-Oct-2023
Ipca Laboratories gains despite reporting 6% fall in Q2 consolidated net profit
Type: MOVERS TODAY
Date: 13-Nov-2023 03:16 PM
Total consolidated income of the company increased by 26.59% at Rs 2,072.51 crore for Q2FY24
Ipca Laboratories reports 6% fall in Q2 consolidated net profit
Type: NEWS
Date: 13-Nov-2023 03:12 PM
Total consolidated income of the company increased by 26.59% at Rs 2,072.51 crore for Q2FY24
Ipca Laboratories reports Profit after tax of Rs 1621.30 Mln, in the September 2023 quarter
Type: CORPORATE RESULT
Date: 10-Nov-2023 01:39 PM
--
Ipca Laboratories gets VAI classification for Indore facility
Type: NEWS
Date: 31-Oct-2023 11:52 AM
USFDA inspected the company’s said manufacturing facility from June 15, 2023 to June 23, 2023
Ipca Laboratories zooms despite getting VAI classification for Madhya Pradesh facility
Type: MOVERS TODAY
Date: 23-Oct-2023 11:50 AM
USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023
Ipca Laboratories gets VAI classification for Madhya Pradesh facility
Type: NEWS
Date: 23-Oct-2023 11:40 AM
USFDA inspected the company’s said manufacturing facility from June 05, 2023 to June 13, 2023